Navigation Links
WebMD Completes Redemption of 3 1/8% Convertible Notes
Date:12/30/2010

NEW YORK, Dec. 30, 2010 /PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasdaq: WBMD) has completed the optional redemption of its 3 1/8% Convertible Notes due 2025.  When the redemption was announced earlier in December, approximately $84.8 million in aggregate principal amount of the 3 1/8% Notes were outstanding.  In lieu of cash redemption, holders of substantially all of those 3 1/8% Notes converted their holdings into approximately 2.4 million shares of WebMD common stock.  The remaining $50 thousand principal amount of the 3 1/8% Notes were redeemed for 100.893% of the principal amount plus accrued interest.  As a result, WebMD no longer has any of the 3 1/8% Notes outstanding.  WebMD expects to take a non-cash pre-tax charge of approximately $7 million during the quarter ending December 31, 2010 related to the conversions and redemptions of the 3 1/8% Notes.

As of December 29, 2010, WebMD had approximately 59.9 million shares of its common stock outstanding, including the shares issued upon conversion of the 3 1/8% Notes and excluding approximately 1.1 million shares of unvested restricted stock.

About WebMD

WebMD Health Corp. (Nasdaq: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers and health plans through our public and private online portals and health-focused publications. More than 80 million unique visitors access the WebMD Health Network each month.

The WebMD Health Network includes WebMD Health, Medscape, MedicineNet, eMedicine, eMedicine Health, RxList, theHeart.org and drugs.com.

All statements contained in this press release, other than statements of historical fact, are forward-looking statements. These statements are based on WebMD's current plans and expectations and involve risks and uncertainties, including those described in our SEC filings.


'/>"/>
SOURCE WebMD
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. WebMD and HLTH Corporation to Webcast Annual Meetings of Stockholders
2. WebMD Launches New Consumer Health Portal in the U.K.
3. WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase Up To 5,700,000 Shares of its Common Stock
4. WebMD to Present at the 2009 Citi Investment Research Small and Mid Cap Conference
5. WebMD Announces 2009 Health Heroes
6. WebMD to Present at the Citi 7th Annual U.S. Small/Mid Cap Conference
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... LONDON , Dec. 6, 2016  "Blood ... all cancers announced ....." The Diagnostic, Monitoring ... revolution in cancer diagnostics is occurring using in ... a new company with impressive backing, has announced ... The technology is moving faster than the market. ...
(Date:12/6/2016)... Dec. 6, 2016 Anaplastic Oligoastrocytoma - ... Markets Direct,s latest Pharmaceutical and Healthcare disease pipeline ... provides an overview of the Anaplastic Oligoastrocytoma (Oncology) ... tumor that forms when two types of cells ... increase in number to form a mass. These ...
(Date:12/6/2016)... Eurofins Genomics today announced it has ... American Pathologists (CAP) and certification under the Clinical ... in Louisville, KY , where ... "Our new CLIA-licensed and CAP-accredited clinical ... considered the ,Gold Standard, method for validation of ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... , ... Facial plastic surgeon, Dr. John D. Rachel of Timeless You™ ... to two local organizations: North Chicago Animal Control and Friends and Our House of ... of authorized and trained volunteers who support rescued animals held in the City of ...
(Date:12/7/2016)... ... 07, 2016 , ... Delete® - Tattoo Removal and Laser Salon Offers Delightful ... Save Up To 33% Off Botox® and Juvederm® Products Now Through December 31, 2016 ... Delightful Deals on Botox® and Juvederm® just in time for the holiday ...
(Date:12/7/2016)... ... December 07, 2016 , ... Texas Premier Locksmith ... carried out by unethical locksmith companies and is urging Search Engines to improve ... to Texas Premier Locksmith, these fraudulent locksmith services take advantage of consumers locked ...
(Date:12/7/2016)... Dallas, TX (PRWEB) , ... December 07, 2016 ... ... a 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. ... Awards recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken ...
(Date:12/7/2016)... Studio City, CA (PRWEB) , ... December 07, 2016 , ... ... number during the holidays and winter seasons. One major study analyzing heart attacks ... January compared to August of a given year. We would all agree of course–no ...
Breaking Medicine News(10 mins):